The Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand, has been working closely with the Health Technology Assessment Committee (HTAC), Ministry of Health, Indonesia, since 2014 under the auspices of the International Decision Support Initiative

Songyot Pilasant1, Wantanee Kulpeng1, Pitsaphun Werayingyong1*, Nattha Tritasavit1, Inthira Yamabhai1, Yot Teerawattananon1, Sangay Wangmo2 and Sripen Tantivess1 Abstract Background: The Maternal and Child Health Voucher Scheme (MCHVS) was introduced in Myanmar to address the high rate of mat

Abstract Nowadays, advanced information technology (IT) has played a key role in all processes of drug supply chain as well as in the national health insurance system. However, the situation of pharmaceutical information systems in Thailand has not been scrutinized and revised since 2002. This st

As economic evaluation methods are constantly changing and developing, it is important to stay abreast of the latest developments so that any beneficial new techniques are utilised, where possible, to maximise the public health impact of health economics and health technology assessment (HT

Puwadol Chawengkul is a research assistant with a research focus on data science. He is passionate about the potential of data science to enhance insightful knowledge in public health policy, leading to better decision-making and healthier communities.

ความก้าวหน้าทางด้านวิทยาศาสตร์ขั้นสูงที่เกี่ยวข้องกับยีนส์ เซลล์และเนื้อเยื่อ ทำให้เกิดนวัตกรรมสำหรับการรักษาโรคที่ไม่

The Thai Ministry of Public Health (MoPH) launched the “Quick Win” campaign in 2023, aimed at providing Human Papillomavirus (HPV) vaccination among unvaccinated girls aged 11 to 20. This campaign increased vaccination coverage from 45% to 80% for girls who received at least one dose. The inc

Thanchanit Thaipitakwong is currently a Senior Content Creator at HITAP, responsible for planning and delivering research communication to the public and developing content in various formats tailored to different audiences and platforms. With a background in pharmacy and experience in medical communication, she focuses on making complex academic c

ABSTRACT Objective Despite treatment availability, chronic hepatitis C virus (HCV) public health burden is rising in India due to lack of timely diagnosis. Therefore, we aim to assess incremental cost per quality-adjusted life year (QALY) for one-time universal screening followed by treatment of